Matthew S. McIlwain

This profile gathers the share dealings of Matthew S. McIlwain across 2 companies, led by Smartsheet Inc and Nautilus Biotechnology, Inc. The record holds 11 filings, for trades running from 17 June 2021 to 22 January 2025.

Every open-market trade on record is a purchase: 5 purchases worth €2.8M, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 4 option exercises.

A typical purchase (the median) is worth €463k. On 1 out of 4 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The record was last updated on 24 January 2025 with a transaction (€7.1M) in Smartsheet Inc. The last purchase on record was published on 21 March 2022, which is 1,672 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.